Clinical Trial Update: StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients [NA]

View source ↗

Summary

A clinical trial evaluating StrataXRT for prevention and treatment of radiation dermatitis in breast cancer or head and neck cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Radiation Dermatitis

Drugs mentioned

• StrataXRT

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Breast Carcinoma, Head and Neck Carcinoma | NA | Status: WITHDRAWN